35181-66-9

Upstream product

• 140-89-6 potassium ethyl xanthogenate 
• 7402-69-9 p-hydroxyphenyl p-tolyl sulfone 
• 80-00-2 4-Chlorophenyl phenyl sulfone 
• 910898-43-0 4-(phenylsulfonyl)phenyl trifluoromethanesulfonate 

Downstream Products

• 58324-85-9 4-(benzenesulfonyl)phenyl methyl sulfide 
• 138870-03-8 4-(phenylsulfonyl)phenyl 2,3,4-tri-O-acetyl-1,5-dithio-β-D-xylopyranoside 
• 35181-67-0 bis-(4-benzenesulfonyl-phenyl)-disulfide 
• 109590-48-9 phenyl-(4-picrylmercapto-phenyl)-sulfone 

Relevant academic research and scientific papers

ARYLSULFONYL BENZOFUSED HETEROCYCLES AS 5-HT2A ANTAGONISTS

Compounds of formula (I): are potent and selective antagonists of the 5-HT2A receptor, and hence are useful in treatment of various CNS disorders.

Therapeutic alcohols

Compounds of formula I STR1 wherein X, A, B, R1 and R2 have the meanings given in the specification, and pharmaceutically acceptable salts and pharmaceutically acceptable in vivo hydrolysable ester thereof, processes for preparing the compounds and pharmaceutical compositions comprising them. The compounds are useful as potassium channel openers and as therapeutic agents in the treatment of urinary incontinence.

Novel sulfonylphenyl-β-D-thioxylosides, their method of preparation and their use in therapeutics

The present invention relates, by way of novel industrial products, to the sulfonylphenyl-β-D-thioxyloside compounds of the formula STR1 in which: X is a sulfur atom or an oxygen atom; R is a C1 -C4 alkyl group, a substituted amino g